TFF Pharma and Augmenta Bioworks Enter Into a Worldwide Joint Development Agreement for COVID-19 Monoclonal Antibody Therapies Read more
Telix Pharma and China Grand Pharma Announce Strategic Licence and Commercial Partnership for Greater China Market Read more
EMA Accepts Biogen’s Aducanumab Marketing Authorization Application for Alzheimer’s Disease Read more
Sanofi offers to acquire Kiadis, a clinical-stage company developing cell-based immunotherapy products Read more
Novartis sickle cell medicine Adakveo approved in Europe to prevent recurrent vaso-occlusive crises Read more
Protagonist Therapeutics Announces Advancement of Oral IL-23 Receptor Antagonists Program in Collaboration with Janssen Read more